In This Article:
Tactile Systems Technology (NASDAQ:TCMD) Full Year 2024 Results
Key Financial Results
-
Revenue: US$293.0m (up 6.8% from FY 2023).
-
Net income: US$17.0m (down 41% from FY 2023).
-
Profit margin: 5.8% (down from 10% in FY 2023). The decrease in margin was driven by higher expenses.
-
EPS: US$0.71 (down from US$1.24 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Tactile Systems Technology EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 15%.
In the last 12 months, the only revenue segment was Surgical & Medical Equipment contributing US$293.0m. The largest operating expense was Sales & Marketing costs, amounting to US$112.0m (56% of total expenses). Explore how TCMD's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 8.3% p.a. on average during the next 2 years, compared to a 7.9% growth forecast for the Medical Equipment industry in the US.
Performance of the American Medical Equipment industry.
The company's shares are down 7.9% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 1 warning sign for Tactile Systems Technology that you need to be mindful of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.